Patents by Inventor An Cerdobbel
An Cerdobbel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240294617Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: January 4, 2024Publication date: September 5, 2024Applicant: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
-
Patent number: 11897944Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: GrantFiled: January 17, 2018Date of Patent: February 13, 2024Assignee: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
-
Publication number: 20230060574Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: June 29, 2022Publication date: March 2, 2023Applicant: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
-
Publication number: 20230050615Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: June 29, 2022Publication date: February 16, 2023Applicant: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
-
Patent number: 11414481Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: GrantFiled: January 17, 2018Date of Patent: August 16, 2022Assignee: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
-
Patent number: 11414480Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: GrantFiled: December 7, 2017Date of Patent: August 16, 2022Assignee: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
-
Publication number: 20190367598Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: January 17, 2018Publication date: December 5, 2019Applicant: Ablynx N.V.Inventors: Stephanie STAELENS, Soren STEFFENSEN, Erika MORIZZO, An CERDOBBEL
-
Publication number: 20190367596Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: December 7, 2017Publication date: December 5, 2019Applicant: Ablynx N.V.Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
-
Publication number: 20190367597Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.Type: ApplicationFiled: January 17, 2018Publication date: December 5, 2019Applicant: Ablynx N.V.Inventors: Stephanie STAELENS, Soren STEFFENSEN, Erika MORIZZO, An CERDOBBEL
-
Publication number: 20130029384Abstract: The present invention relates to a sucrose phosphorylase from Bifidobacterium adolescentis which is useful as a biocatalyst in carbohydrate conversions at high temperatures. Indeed, the biocatalysts of the present invention are enzymatically active for a time period of at least 16 h and up to 1 to 2 week(s) at a temperature of at least 60° C. The biocatalysts of the present invention are: a) immobilized on an enzyme carrier, or b) are part of a cross-linked enzyme aggregate (CLEA), and/or c) are mutated, and/or d) are enzymatically active in the continuous presence of their substrate.Type: ApplicationFiled: April 1, 2011Publication date: January 31, 2013Applicant: UNIVERSITEIT GENTInventors: An Cerdobbel, Tom Desmet, Wim Soetaert
